Our Story

Biogenes Global is a holding company representing companies globally plugged into our vision of diagnostic simplified

2015

Biogenes Technologies is incorporated in Malaysia with the 3 founders.

image
image
2016

Licensed technology from Malaysian university, UKM on Arowana fish gender testing using DNA-based biosensor.

2017

Biosensor technology breakthrough platform.

image
image
2018

Began exploring aptamer-based technology for faster development of more diagnostic products.

2019

Aptamer technology breakthrough ingredient design platform.

image
image
2020

Covidsens - first diagnostics launched.

2021

APTCAD aptamer design technology launched.

image
image
2022

APTFAB foundry for biosensor launched.

2023

APTSENS diagnostocs platform launched for digital diagnostics. New 10,000 sqft R&D facility launched. Biogenes hit milestone of 300 aptamers.

image
image
2024

Launched two diagnostic products for local R&D outcomes; field test kit for paddy disease and aptamer-based HPV staining kit.

2025

Biogenes Technologies Limited launched in the UK. Biogenes aims to seek out new opportunities, increase the use of platform technologies and build a global portfolio of Intellectual Properties.

image

Biogenes Global has companies in Malaysia (R&D and manufacturing), partners in Malaysia Austria, UK and USA working together towards simplifying diagnostics solutions in: